Ensayo controlado citisina versus placebo para la cesación del tabaquismo
Ensayo controlado citisina versus placebo para la cesación del tabaquismo
Issue
Section
Journal clubs
How to Cite
Ensayo controlado citisina versus placebo para la cesación del tabaquismo.
rev. colomb. neumol. [Internet]. 2016 May 24 [cited 2024 Nov. 23];26(4). Disponible en: https://doi.org/10.30789/rcneumologia.v26.n4.2014.10
Dimensions
license
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Article visits 619 | PDF visits 1313
Downloads
Download data is not yet available.
- Alba LH, Murillo R, Becerra N, Páez N, Cañas A, Mosquera C, et al. Recomendaciones para la cesación de la adicción al tabaco en Colombia: guía de práctica clínica basada en la evidencia. Biomédica.
- ; 33(2) 186-204.
- Ministerio de la Protección Social, Colciencias, CENDEX, S.E.I S.A. Encuesta Nacional de Salud 2007. 1ª Ed. Bogotá D.C.: Ministerio de la Protección Social; 2009.
- Ministerio de Salud. II Estudio nacional de factores de riesgo de enfermedades crónicas- ENFREC II. Bogotá D.C: Ministerio de Salud; 1999.
- República de Colombia. Ley 1335 de 2009. Diario Oficial No. 47.417 de 21 de julio de 2009.
- Lemmens V, Oenema A, Knut IK, Bruj J. Effectiveness of smoking cessation intervention among adults: a systematic review of reviews. Eur J Cancer Preven. 2008;17:535-44. doi.org/10.1097/CEJ.0b013e3282f75e48
- Fiore MC, Jaén CR, Baker TB, Bailey WC. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service;
- National Institute for Health and Clinical Excellence (NICE). Brief interventions and referral for smoking cessation in primary care and other. Marzo, 2006.
- Ministry of Health. New Zealand smoking cessation guidelines. Wellington: Ministry of Health; 2007.
- Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;1:CD000031.http://dx.doi.org/10.1002/14651858.CD000031
- Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006;6:300. doi.org/10.1186/1471-2458-6-300
- Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011;183:1359-66. .doi.org/10.1503/
- cmaj.110218
- Wagena EJ, Knipschild P, Zeegers MP. Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction. 2005;100:317-26. doi.org/10.1111/j.1360-0443.2005.00998.x
- Ministry of Health. New Zealand smoking cessation guidelines. Wellington: Ministry of Health; 2007.
- Gourlay SG, Stead LF, Benowitz N. Clonidine for smoking cessation (Review). Cochrane Database Syst Rev. 2004;3:CD000058. doi.org/10.1002/14651858.CD000058.pub2
- National Institute for Health and Clinical Excellence (NICE). Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women
- and hard to reach communities. London: National Institute for Health and Clinical Excellence; 2008.
- Etter JF. Cytisine for smoking cessation: a literature review and a metaanalysis. Arch Intern Med. 2006;166:1553-9.
- Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax. 2013;68:1037-42.
- Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Syst Rev. 2011;2:CD006103.